Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Study Evaluating Once Every Other Week Subcutaneous Administration of Aranesp (Darbepoetin Alfa) in Subjects With Anemia of Chronic Renal Insufficiency (CRI)

NCT00369772 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00369772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00369772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Study Evaluating Once Every Other Week Subcutaneous Administration of Aranesp (Darbepoetin Alfa) in Subjects With Anemia of Chronic Renal Insufficiency (CRI)
Lead sponsor
Amgen
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2002
Completion date
May 31, 2004
Enrollment
2,000
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, chronic renal insufficiency, kidney disease, pre-dialysis, pre-esrd